My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2026/1826 of 28 July 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, amisulbrom, Bacillus amyloliquefaciens strain MBI 600, beflubutamid, clomazone, cyantraniliprole, cyprodinil, daminozide, dichlorprop-P, dimethachlor, fludioxonil, formetanate, fosetyl, isofetamid, metalaxyl, metazachlor, penconazole, phenmedipham, pirimicarb, pyraclostrobin and S-abscisic acid

Commission Implementing Regulation (EU) 2026/1826 of 28 July 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, amisulbrom, Bacillus amyloliquefaciens strain MBI 600, beflubutamid, clomazone, cyantraniliprole, cyprodinil, daminozide, dichlorprop-P, dimethachlor, fludioxonil, formetanate, fosetyl, isofetamid, metalaxyl, metazachlor, penconazole, phenmedipham, pirimicarb, pyraclostrobin and S-abscisic acid

Implementing Regulation (EU) 2026/1826 · Regulation · 3 articles

Data as of 2026-08-06 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) Part A is amended as follows: (1) in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by ‘15 December 2026’; (2) in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘30 September 2027’; (3) in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘15 December 2027’; (4) in the sixth column, expiration of approval, of row 124, Pirimicarb, the date is replaced by ‘31 July 2027’; (5) in the sixth column, expiration of approval, of row 130, Cyprodinil, the date is replaced by ‘31 July 2027’; (6) in the sixth column, expiration of approval, of row 131, Fosetyl, the date is replaced by ‘31 January 2028’; (7) in the sixth column, expiration of approval, of row 133, Dichlorprop-P, the date is replaced by ‘31 October 2027’; (8) in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘30 September 2027’; (9) in the sixth column, expiration of approval, of row 158, Beflubutamid, the date is replaced by ‘31 July 2028’; (10) in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘30 September 2027’; (11) in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 December 2027’; (12) in the sixth column, expiration of approval, of row 215, Aclonifen, the date is replaced by ‘31 March 2029’; (13) in the sixth column, expiration of approval, of row 217, Metazachlor, the date is replaced by ‘31 May 2029’; (14) in the sixth column, expiration of approval, of row 284, Dimethachlor, the date is replaced by ‘31 March 2029’; (15) in the sixth column, expiration of approval, of row 287, Penconazole, the date is replaced by ‘15 February 2029’; (16) in the sixth column, expiration of approval, of row 304, Metalaxyl, the date is replaced by ‘30 June 2029’; (2) Part B is amended as follows: (1) in the sixth column, expiration of approval, of row 65, S-abscisic acid, the date is replaced by ‘15 April 2029’; (2) in the sixth column, expiration of approval, of row 69, Amisulbrom, the date is replaced by ‘15 March 2030’; (3) in the sixth column, expiration of approval, of row 99, Cyantraniliprole, the date is replaced by ‘14 March 2030’; (4) in the sixth column, expiration of approval, of row 100, Isofetamid, the date is replaced by ‘15 March 2030’; (5) in the sixth column, expiration of approval, of row 101, Bacillus amyloliquefaciens strain MBI 600, the date is replaced by ‘1 December 2029’.

Other acts of the same type
Commission Delegated Regulation (EU) 2022/139 of 16 November 2021 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the management, storage and replacement of stocks of the Union antigen, vaccine and diagnostic reagent banks and the biosecurity, biosafety and bio-containment requirements for the operation of those banks (Text with EEA relevance)Commission Implementing Regulation (EU) 2022/140 of 16 November 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council with regard to the Union antigen, vaccine and diagnostic reagent banks (Text with EEA relevance)Council Implementing Regulation (EU) 2021/1983 of 15 November 2021 implementing Regulation (EU) No 36/2012 concerning restrictive measures in view of the situation in SyriaCouncil Regulation (EU) 2021/1985 of 15 November 2021 amending Regulation (EC) No 765/2006 concerning restrictive measures in respect of BelarusCouncil Regulation (EU) 2021/1986 of 15 November 2021 amending Regulation (EC) No 765/2006 concerning restrictive measures in respect of BelarusCommission Implementing Regulation (EU) 2021/2028 of 15 November 2021 approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (‘Cerezas de la Montaña de Alicante’ (PGI))Commission Regulation (EU) 2021/1973 of 12 November 2021 correcting the German language version of Regulation (EU) No 142/2011 implementing Regulation (EC) No 1069/2009 of the European Parliament and of the Council laying down health rules as regards animal by-products and derived products not intended for human consumption and implementing Council Directive 97/78/EC as regards certain samples and items exempt from veterinary checks at the border under that Directive (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/1974 of 12 November 2021 authorising the placing on the market of dried fruits of Synsepalum dulcificum as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/1975 of 12 November 2021 authorising the placing on the market of frozen, dried and powder forms of Locusta migratoria as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/1976 of 12 November 2021 imposing a definitive anti-dumping duty and definitively collecting the provisional duty imposed on imports of mono ethylene glycol originating in the United States of America and the Kingdom of Saudi ArabiaCommission Implementing Regulation (EU) 2021/1977 of 12 November 2021 amending Annexes V and XIV to Implementing Regulation (EU) 2021/404 as regards the entries for the United Kingdom in the lists of third countries authorised for the entry into the Union of consignments of poultry, germinal products of poultry and fresh meat of poultry and game birds (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/2023 of 12 November 2021 approving Union amendment to the specification for a Protected Designation of Origin or a Protected Geographical Indication (‘Soave’ (PDO))

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next